Quarterly ResultMay 5, 2026, 11:57 AM
DuPont Q1 Net Income $164M; Completes Aramids Divestiture; Plans Reverse Split
AI Summary
DuPont reported a net income of $164 million for Q1 2026, a significant improvement from a net loss of $581 million in Q1 2025. Income from continuing operations rose to $150 million from $80 million year-over-year. The company completed the divestiture of its Aramids business for $1.8 billion gross consideration on April 1, 2026, and announced plans for a reverse stock split at a ratio of 1-for-2 to 1-for-4, subject to stockholder approval. Additionally, DuPont initiated a new restructuring program, anticipating $80 million in pre-tax charges through 2028, with $52 million incurred in Q1 2026.
Key Highlights
- Completed Aramids Divestiture on April 1, 2026, for $1.8 billion gross consideration.
- Announced plans for a reverse stock split at a ratio of 1-for-2 to 1-for-4.
- Reported Q1 2026 net income of $164 million, up from a $581 million net loss in Q1 2025.
- Income from continuing operations increased to $150 million in Q1 2026 from $80 million in Q1 2025.
- Basic EPS from continuing operations was $0.36 in Q1 2026, up from $0.19 in Q1 2025.
- Initiated 2026 restructuring program, incurring $52 million in Q1 2026 charges.
- Healthcare & Water Technologies net trade revenue was $806 million in Q1 2026.
- Diversified Industrials net trade revenue was $875 million in Q1 2026.